Detalhe da pesquisa
1.
Methylation of promoter region of BRCA1 gene versus pathogenic variants of gene: risk factor or clinical marker of breast cancer.
Breast Cancer Res Treat
; 196(3): 505-515, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36284026
2.
Contribution of BRCA1 5382insC mutation to triplene-gative and luminal types of breast cancer in Ukraine.
Breast Cancer Res Treat
; 195(3): 453-459, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35930098
3.
Clinical significance of determining the hypermethylation of the RUNX3 gene promoter and its cohypermethylation with the BRCA1 gene for patients with breast cancer.
J Cancer Res Clin Oncol
; 149(13): 11919-11927, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37420018
4.
Mutations c.459+1G>A and p.P426L in the ARSA gene: prevalence in metachromatic leukodystrophy patients from European countries.
Mol Genet Metab
; 86(3): 353-9, 2005 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-16140556
5.
Novel mutations in arylsulfatase A gene in three Ukrainian families with metachromatic leukodystrophy.
Mol Genet Metab
; 80(3): 360-3, 2003 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-14680985